Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression
In the Phase 3 study population (N=90) of patients with PPD, LPCN 1154 did not show a statistically…
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
– PGN-EDODM1 was generally well-tolerated with all adverse events mild or moderate and no serious adverse events reported…
ENvue Medical Expands Presence within a Major Michigan Health System and Grows U.S. Hospital Footprint to 39
ENvue Medical, Inc. Premier 714-bed teaching hospital and Level I Trauma Center purchases ENvue™ Navigation Platform system and…
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Tonix Pharmaceuticals Holding Corp. TONMYA™ (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia;…
The Top 3 Artificial Intelligence (AI) Chip Stocks to Buy With $50,000 in 2026
Over the last few years, technology investors have witnessed unprecedented sums poured into artificial intelligence (AI) infrastructure. Hyperscalers…
BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®
BioXcel Therapeutics Company remains focused on potential approval and launch of IGALMI® for the acute treatment of agitation…
WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer
WORK Medical Technology Group LTD Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) — WORK Medical Technology Group LTD…
Amphastar Announces FDA Approval for Teriparatide Injection
RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the…
The Biggest Risk to Your Portfolio Isn’t Missing AI — It’s Holding These 2 Stocks When the Hype Fades
CoreWeave now pays roughly six times its gross profit just to service interest on its ever-growing debt load.…
Alarum Technologies Reports Record Third Quarter Revenue Growth of 81% to $13 Million Driven by Surging Demand from Leading AI Model Developers
Alarum Technologies Ltd. Company Diligently Prioritizing Market-Share Capture in Explosive AI Training-Data Segment TEL AVIV, Israel, Nov. 26,…
Meta’s Chief AI Scientist is leaving the company after 12 years
One of Meta’s top AI researchers, Yann LeCun, is leaving after 12 years with the company to found…
BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s Disease
BioXcel Therapeutics sNDA submission expected in early Q1 2026 for expanded usage of IGALMI® in home setting based…